“The FDA clarification significantly changes the formulation landscape for tagatose as a primary sweetener across better-for-you categories,” said Thom King, chief innovations officer at Icon Foods. “For years, formulators have recognized tagatose’s functional advantages and low glycemic response, but the added sugar labeling requirement limited broader adoption. The FDA clarification removes that barrier and creates new opportunities for brands looking to reduce sugar.”

Tagatose is a rare sugar naturally occurring in small quantities in dairy products. It delivers approximately 90% of the sweetness of sucrose with a near-identical sweetness curve, while containing roughly 60% fewer calories. It is considered a low-glycemic sweetener and has been shown to support prebiotic fermentation by feeding beneficial gut bacteria. Beyond sweetness, tagatose provides many of the key functional properties of sucrose, including browning, bulk and texture.

TagaLite is Icon Foods’ branded tagatose ingredient, providing manufacturers with a ready-to-formulate sweetener that delivers sugar-like functionality and clean sweetness. It supports diabetic-, keto- and GLP-1–friendly product development, reflecting growing demand for reduced-sugar solutions that maintain taste and texture expectations. 

TagaLite is particularly well-suited for baked goods, dairy products, beverages, frozen applications, confectionery and better-for-you snacks. In frozen systems, it contributes freeze-point depression and ice crystallization control, helping create smoother, creamier textures in reduced-sugar products. In baked applications, its participation in Maillard delivers a golden color and flavor similar to sucrose.

“TagaLite provides manufacturers with a highly functional, low-calorie sweetener option for sugar reduction,” said King. “Formulators can rebuild sugar’s role in texture, browning, bulk and freeze control, with a clean sweetness that behaves like sugar in real-world applications.”